ATE125870T1 - Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. - Google Patents

Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.

Info

Publication number
ATE125870T1
ATE125870T1 AT88403036T AT88403036T ATE125870T1 AT E125870 T1 ATE125870 T1 AT E125870T1 AT 88403036 T AT88403036 T AT 88403036T AT 88403036 T AT88403036 T AT 88403036T AT E125870 T1 ATE125870 T1 AT E125870T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
hiv
hybridomas
production
specific monoclonal
Prior art date
Application number
AT88403036T
Other languages
English (en)
Inventor
Yasuhiko Masuho
Toru Sugano
Yoh-Ichi Matsumoto
Evan Hersh
Eskild Petersen
Douglas Arizona Health Sc Lake
Medicine
Original Assignee
Univ Arizona
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona, Teijin Ltd filed Critical Univ Arizona
Application granted granted Critical
Publication of ATE125870T1 publication Critical patent/ATE125870T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT88403036T 1988-03-31 1988-12-01 Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. ATE125870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/176,159 US5298419A (en) 1988-03-31 1988-03-31 Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus

Publications (1)

Publication Number Publication Date
ATE125870T1 true ATE125870T1 (de) 1995-08-15

Family

ID=22643233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88403036T ATE125870T1 (de) 1988-03-31 1988-12-01 Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.

Country Status (8)

Country Link
US (1) US5298419A (de)
EP (1) EP0339163B1 (de)
JP (2) JPH0753755B2 (de)
KR (1) KR0149848B1 (de)
AT (1) ATE125870T1 (de)
AU (1) AU627698B2 (de)
CA (1) CA1339858C (de)
DE (1) DE3854267T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007878A1 (en) * 1990-10-26 1992-05-14 The Public Health Research Institute Of The City Of New York, Inc. Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
US6030804A (en) * 1995-06-06 2000-02-29 Human Genome Sciences, Inc. Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US7115262B1 (en) 1999-03-16 2006-10-03 The United States Of America As Represented By The Department Of Health And Human Services Chimeric protein for prevention and treatment of HIV infection
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
JP4277490B2 (ja) * 2001-08-27 2009-06-10 セイコーエプソン株式会社 マイクロカプセル化顔料及びその製造方法、水性分散液、並びに、インクジェット記録用インク
EP1868639B1 (de) * 2005-03-07 2010-08-25 Albert Einstein College Of Medicine Of Yeshiva University Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie
CA2623197A1 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
BR112012000032A2 (pt) * 2009-07-03 2016-03-15 Bionor Immuno As meios terapêuticos e diagnósticos inovadores
JP2019509046A (ja) 2015-12-05 2019-04-04 サントル オスピタリエ ユニヴェルシテール ヴォドアＣｅｎｔｒｅ Ｈｏｓｐｉｔａｌｉｅｒ Ｕｎｉｖｅｒｓｉｔａｉｒｅ Ｖａｕｄｏｉｓ Ｈｉｖ結合剤
WO2020012435A1 (en) 2018-07-13 2020-01-16 Lausanne University Hospital Hiv binding agents
JP2022541900A (ja) 2019-07-15 2022-09-28 ローザンヌ ユニヴァーシティ ホスピタル Ｈｉｖ結合剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536337Y2 (de) * 1976-03-29 1980-08-27
US4363799A (en) * 1979-03-20 1982-12-14 Ortho Pharmaceutical Corporation Monoclonal antibody to human T cells, and methods for preparing same
US4515894A (en) * 1979-03-20 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human T cells
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
JPS6349316U (de) * 1986-09-17 1988-04-04
JPS63105619U (de) * 1986-12-26 1988-07-08

Also Published As

Publication number Publication date
CA1339858C (en) 1998-05-05
AU627698B2 (en) 1992-09-03
EP0339163A2 (de) 1989-11-02
KR0149848B1 (ko) 1999-03-30
JPH07292000A (ja) 1995-11-07
DE3854267T2 (de) 1996-01-04
EP0339163B1 (de) 1995-08-02
AU2456888A (en) 1989-10-05
DE3854267D1 (de) 1995-09-07
US5298419A (en) 1994-03-29
JPH0753755B2 (ja) 1995-06-07
EP0339163A3 (en) 1990-05-09
JPH02219592A (ja) 1990-09-03
KR890014730A (ko) 1989-10-25

Similar Documents

Publication Publication Date Title
EP0671920A4 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten.
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ATE280783T1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
DE3854267T2 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
EP0141079A3 (en) Monoclonal antibodies specific for membrane-associated antigens
DE3776133D1 (de) Brennstoffbuendel und reaktor.
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
DE3689868D1 (de) Monoklonale Antikörper gegen menschliches Plasma-Prekallikrein und Verfahren zu ihrer Herstellung und Verwendung.
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
DE3786173T2 (de) Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten.
IT9022010A0 (it) Procedimento per la utilizzazione dirifiuti organici per la produzionedi biogas e di prodotti per l'agricoltura.
PT85278A (fr) Procede de preparation d:une fraction immunogene active a liegard des bilharzioses et de compositions immunisantes la contenant
EE03170B1 (et) Perifeerse vere mononukleaarsete rakkude tsütotoksilise aktiivsuse stimuleerimine IL-10 abil
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
DE68922826D1 (de) Verwendung einer Zusammensetzung, die organisch gebundenes Germanium enthaltet, zur Herstellung von Arzneimitteln zur Behandlung von AIDS.
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
EP0453419A3 (en) Use of the sp-2 monoclonal antibody for diagnostics and for monitoring of the hiv infection progress
ATE84069T1 (de) Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist.
NO872633L (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee